Jacobs Levy Equity Management
PSTX

Jacobs Levy Equity Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Jacobs Levy Equity Management’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-811,512
Closed -$2.32M – 1067
2024
Q3 		$2.32M Sell
811,512
-115,494
-12% -$358K 0.01% 573
2024
Q2 		$2.71M Buy
927,006
+96,879
+12% +$265K 0.01% 554
2024
Q1 		$2.65M Buy
830,127
+391,801
+89% +$1.31M 0.01% 551
2023
Q4 		$1.47M Buy
+438,326
New +$1.13M 0.01% 656
2022
Q3 		– Sell
-90,445
Closed -$233K – 1197
2022
Q2 		$233K Buy
90,445
+76,233
+536% +$212K ﹤0.01% 950
2022
Q1 		$64K Sell
14,212
-314,169
-96% -$1.42M ﹤0.01% 984
2021
Q4 		$2.24M Sell
328,381
-16,563
-5% -$113K 0.02% 598
2021
Q3 		$2.52M Sell
344,944
-19,227
-5% -$165K 0.02% 568
2021
Q2 		$3.65M Sell
364,171
-20,645
-5% -$185K 0.02% 494
2021
Q1 		$3.67M Buy
384,816
+359,002
+1,391% +$3.52M 0.03% 481
2020
Q4 		$283K Buy
+25,814
New +$272K ﹤0.01% 932

Other funds holding PSTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Jacobs Levy Equity Management's PSTX Position: Q4 2024 in Review

Jacobs Levy Equity Management sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q4 2024, closing a stake of 811,512 shares — an estimated $2.32M sold.

Jacobs Levy Equity Management first reported a position in PSTX in Q4 2020 and held it in 11 quarters. The position peaked at $3.67M in Q1 2021. 115 funds tracked by Wall St. Rank hold PSTX as of Q4 2024.

  • Jacobs Levy Equity Management reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 811,512 Poseida Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $2.32M.
  • Jacobs Levy Equity Management first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • Jacobs Levy Equity Management's Poseida Therapeutics, Inc. Common Stock position peaked at $3.67M in Q1 2021.
  • 115 funds tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2024, filed 14 Feb 2025.